Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 15,944 shares at $13.39 ($213K) on 2025-08-12, disclosed to the SEC on 2025-08-14.
Open-market sale of $213k EWTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.39 | 7,972 | $107K | 50.0% |
| 2 | $13.39 | 7,972 | $107K | 50.0% |
| Total | $13.39 avg | 15,944 | $213K | 100% |
| Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $119K | — | Filing → |